AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $9.50 million. The enterprise value is $13.19 million.

Market Cap	9.50M
Enterprise Value	13.19M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

AEON Biopharma has 11.31 million shares outstanding. The number of shares has decreased by -98.12% in one year.

Current Share Class	11.31M
Shares Outstanding	11.31M
Shares Change (YoY)	-98.12%
Shares Change (QoQ)	+617.55%
Owned by Insiders (%)	30.06%
Owned by Institutions (%)	19.90%
Float	7.86M

Valuation Ratios

The trailing PE ratio is 0.01.

PE Ratio	0.01
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.08
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43

Current Ratio	1.43
Quick Ratio	1.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-158.88%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-414.67%
Revenue Per Employee	n/a
Profits Per Employee	$33.82M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.88% in the last 52 weeks. The beta is 0.57, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-98.88%
50-Day Moving Average	0.62
200-Day Moving Average	24.28
Relative Strength Index (RSI)	60.14
Average Volume (20 Days)	427,674

Short Selling Information

The latest short interest is 433,279, so 3.83% of the outstanding shares have been sold short.

Short Interest	433,279
Short Previous Month	176,612
Short % of Shares Out	3.83%
Short % of Float	5.51%
Short Ratio (days to cover)	0.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.39M
Pretax Income	n/a
Net Income	169.12M
EBITDA	-21.30M
EBIT	-21.39M
Earnings Per Share (EPS)	$117.22

Full Income Statement

Balance Sheet

The company has $10.45 million in cash and $14.60 million in debt, giving a net cash position of -$4.15 million or -$0.37 per share.

Cash & Cash Equivalents	10.45M
Total Debt	14.60M
Net Cash	-4.15M
Net Cash Per Share	-$0.37
Equity (Book Value)	-11.32M
Book Value Per Share	-1.07
Working Capital	3.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.60 million and capital expenditures -$4,000, giving a free cash flow of -$19.61 million.

Operating Cash Flow	-19.60M
Capital Expenditures	-4,000
Free Cash Flow	-19.61M
FCF Per Share	-$1.73

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	98.12%
Shareholder Yield	98.12%
Earnings Yield	1,872.23%
FCF Yield	-217.04%

Analyst Forecast

The average price target for AEON Biopharma is $360.00, which is 42,757.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$360.00
Price Target Difference	42,757.14%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.01388889:1.

Last Split Date	Feb 26, 2025
Split Type	Reverse
Split Ratio	0.01388889:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2